Home Podcasts inSpired
inSpired

inSpired

Woodline Partners 2 Episodes Sep 1, 2026

Mike Rockefeller, Co-Chief Investment Officer of Woodline, manager of the Woodline | Spire funds, sits down with executives building tomorrow’s great companies. Candid, strategic conversations. For investors, by an investor. This is inSpired.

Episodes

Joe Kudla, CEO of Vuori: The Discipline Behind a Decade of Growth
Joe Kudla, CEO of Vuori: The Discipline Behind a Decade of Growth Sep 1, 2026 3236 On this episode of inSpired, Mike Rockefeller, Co-Chief Investment Officer of Woodline, is joined by his colleague Neetu Dhaliwal to sit down with Joe Kudla, Founder & CEO of Vuori, at its headquarters in Carlsbad, California. Kudla traces Vuori's path from an Encinitas garage to a global brand, its fabric-first design philosophy, and the decision to build the company on free cash flo
Dr. Len Schleifer, CEO of Regeneron: Betting on Science and Saving a President
Dr. Len Schleifer, CEO of Regeneron: Betting on Science and Saving a President Jun 2, 2026 3634 On this episode of inSpired, Mike Rockefeller, Co-Chief Investment Officer of Woodline, sits down with Dr. Leonard Schleifer, Co-Founder, President & CEO of Regeneron, at its headquarters in New York. Len reflects on the 38-year journey of building Regeneron alongside co-founder Dr. George Yancopoulos, the company's deep pipeline, and the extraordinary story of treating President Trum
Dave Ricks, CEO of Eli Lilly: How a 150 Year Old Company Keeps Winning
Dave Ricks, CEO of Eli Lilly: How a 150 Year Old Company Keeps Winning Apr 21, 2026 3812 On this episode of inSpired, Mike Rockefeller, Co-Chief Investment Officer of Woodline, manager of the Woodline | Spire funds, sits down with Dave Ricks, Chair & CEO of Eli Lilly, at its headquarters in Indiana. Ricks dives into the market for GLP-1s, a wide range of potential future applications, and upcoming pipeline drugs like retatrutide and eloralintide. They explore obesity pric

Recommended